The Board of Directors of DSM-Firmenich AG has authorized a buyback plan on April 8, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
106.6 CHF | -0.14% | -0.42% | +15.82% |
May. 28 | Elanco Says FDA Confirms Bovaer Meets Safety, Efficacy Requirements | MT |
May. 07 | Dsm-Firmenich Ag Approves Retirement of Pradeep Pant from the Board | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.82% | 30.74B | |
+12.23% | 872B | |
0.00% | 239B | |
+32.07% | 185B | |
-5.02% | 130B | |
+55.90% | 94.15B | |
-9.36% | 70.84B | |
-9.73% | 54.61B | |
+34.99% | 37.62B | |
-43.30% | 29.95B |
- Stock Market
- Equities
- DSFIR Stock
- News Danube AG
- DSM-Firmenich AG authorizes a Buyback Plan.